Karyopharm Therapeutics
KPTI
KPTI
90 hedge funds and large institutions have $298M invested in Karyopharm Therapeutics in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 25 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
90
Holders Change
+13
Holders Change %
+16.88%
% of All Funds
2.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
32
Reduced
25
Closed
5
Calls
$1.19M
Puts
$242K
Net Calls
+$951K
Net Calls Change
-$227K
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$3.88M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.36M |
| 3 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$1.16M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$1.03M |
| 5 |
IHM
Iguana Healthcare Management
New York
|
-$960K |
